TLIS Total Utang marang Modal Talis Biomedical Corp.

Lambang korporat lan logo Talis Biomedical Corp (TLIS)

The Talis Biomedical (TLIS) rapid testing ecosystem is undergoing a painful restructuring due to regulatory challenges and the loss of customers. Meanwhile, Talis Biomedical is developing cloud services for rapid tests, generating revenue through the sale of consumables and instruments. The price history on GURU.Markets shows that the total debt-to-equity ratio is 0.40, while a broad line of infection diagnostic panels effectively mitigates seasonality risks.

TLIS: Total Utang marang Modal Talis Biomedical Corp. 04.07.2022 - 07.09.2024

Rincian metrik komprehensif lan analitis Talis Biomedical Corporation (TLIS)

- rega lan prakiraan konsensus rega:
Rega saham Talis Biomedical Corp.|TLIS - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar Talis Biomedical|TLIS - Rega Tumbas Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Talis Biomedical|TLIS - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku talis.bio|TLIS - Aset Neraca Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Talis Biomedical|TLIS - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Talis Biomedical Corp.|TLIS - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Talis Biomedical
Ringkesan analisis perusahaan:Talis Biomedical - TLIS
Produk mawa merek Talis Biomedical Corp.

The total debt-to-equity ratio measures the proportion of borrowed funds relative to shareholders' equity, determining financial leverage and the extent of the business's dependence on external creditors. By analyzing the total debt/equity chart, an investor can identify the risk of a mismatch between the debt load of Talis Biomedical (TLIS) and its current state of total R&D pipeline stagnation and the cessation of commercial operations for the Talis One platform.

Analisis perusahaan pesaing

Total Utang marang Modal Abbott (ABT)|Rasio Utang marang Ekuitas Thermo Fisher Scientific Inc.|GEHC (GE Healthcare Corp) - Total Utang marang Modal|Koefisien Total Utang marang Modal Mettler Toledo Inc (MTD)|Total Utang marang Modal WAT (Waters Corporation)|Total Utang marang Modal bio-techne.com TECH|Total Utang marang Modal BRKR|AZTA: Rasio Utang marang Modal|Utang marang Ekuitas Varex|SMLR (Semler) - Rasio Utang marang Ekuitas|Utang marang Ekuitas BFLY (Butterfly Network, Inc.)|Utang marang Modal MLAB|QSI (Quantum-Si Incorporated) - Utang marang Ekuitas|Koefisien Total Utang marang Modal Nano-X Imaging NNOX|Rasio Total Utang marang Ekuitas Quanterix Corp (QTRX)|Utang Agregat marang Modal 908 Devices Corporation MASS|Total Utang marang Modal CV (CapsoVision Medical)|MXCT - Koefisien Total Utang marang Modal|RPID (rapidmicrobio.com) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Seer Inc|HYPR - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi FONR|Utang marang Ekuitas DXR (Daxor Corporation)|Rasio Total Utang marang Ekuitas Spectral AI Inc. (MDAI)|VIVS: Total Utang marang Modal|Utang marang Modal Aclarion Inc ACON|Akoya (AKYA) - Total Utang marang Modal|THMO - Rasio Utang marang Ekuitas|T2 Biosystems, Inc. - Total Utang marang Modal